Alex Wong, CEO of Xcelom sat down with PharmaBoardroom to discuss the company’s non-invasive prenatal testing (NIPT) technology and increasing capacity in the field of screening for chromosomal disorders. Wong sheds light on the Asian diagnostics market and unveils his strategy to expand Xcelom’s offering across Asia.
Our pursuit and pioneering of cutting edge improvements, along with our partnerships with various medical expert KOLs in Hong Kong, are what made us the NIPT market leader we are today
